Navidea Biopharmaceuticals Inc
OTC:NAVB

Watchlist Manager
Navidea Biopharmaceuticals Inc Logo
Navidea Biopharmaceuticals Inc
OTC:NAVB
Watchlist
Price: 0.0005 USD Market Closed
Market Cap: 50k USD

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value of NAVB.

The Intrinsic Value is calculated as the average of DCF and Relative values:

NAVB Intrinsic Value
Not Available
Base Case Scenario
Compare NAVB to

Fundamental Analysis

Company Overview
Loading...
Earnings Call
Loading...
Contacts
Loading...
How do you feel about NO1A?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Navidea Biopharmaceuticals Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Navidea Biopharmaceuticals Inc

Current Assets 4.5m
Cash & Short-Term Investments 3.9m
Receivables 30.9k
Other Current Assets 607.3k
Non-Current Assets 1.2m
PP&E 119.4k
Intangibles 1.1m
Other Non-Current Assets 11.8k
Efficiency

Free Cash Flow Analysis
Navidea Biopharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Navidea Biopharmaceuticals Inc

Revenue
0 USD
Cost of Revenue
-50k USD
Gross Profit
-50k USD
Operating Expenses
-10.1m USD
Operating Income
-10.2m USD
Other Expenses
8.8m USD
Net Income
-1.4m USD
Fundamental Scores

NAVB Profitability Score
Profitability Due Diligence

Navidea Biopharmaceuticals Inc's profitability score is 71/100. The higher the profitability score, the more profitable the company is.

Exceptional 3Y Average ROIC
Exceptional 3Y Average ROE
Exceptional ROIC
ROIC is Increasing
71/100
Profitability
Score

Navidea Biopharmaceuticals Inc's profitability score is 71/100. The higher the profitability score, the more profitable the company is.

NAVB Solvency Score
Solvency Due Diligence

Navidea Biopharmaceuticals Inc's solvency score is 34/100. The higher the solvency score, the more solvent the company is.

Low D/E
Negative Net Debt
Long-Term Solvency
Short-Term Solvency
34/100
Solvency
Score

Navidea Biopharmaceuticals Inc's solvency score is 34/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

NAVB Price Targets Summary
Navidea Biopharmaceuticals Inc

There are no price targets for NAVB.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for NO1A is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y